NCT05423704View on ClinicalTrials.gov

Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark

NAActive, not recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

November 14, 2021

Study Completion Date

May 14, 2026

Conditions
Head-and-neck Cancer
Interventions
OTHER

Proton radiotherapy

Proton radiotherapy according to the guidelines defined by the Danish Head-Neck Cancer Group (DAHANCA). Treatment: 66-68 Gy/ 33-34 fx/ 6/W, with cisplatin 40 mg/m2/W and nimorazole to suitable patients

Trial Locations (7)

Unknown

Aalborg University Hospital, Aalborg

Aarhus University Hospital, Aarhus

Danish Center for Particle Therapy, Aarhus

Rigshospitalet, Copenhagen

Herlev Hospital, Herlev

Næstved Hospital, Næstved

Odense University Hospital, Odense

All Listed Sponsors
lead

Danish Head and Neck Cancer Group

NETWORK

NCT05423704 - Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark | Biotech Hunter | Biotech Hunter